Understanding Carpal Tunnel Syndrome

Carpal Tunnel Syndrome (CTS) is a condition that can severely impact everyday activities. It manifests as numbness, tingling, and pain in the hand due to compression of the median nerve, which runs through a narrow tunnel at the wrist. These symptoms can make simple tasks, such as typing or holding a pen, feel daunting.

Recent Findings from Clinical Trials

Innovative research has uncovered that injecting saline around the compressed nerve may provide longer-lasting relief from CTS symptoms compared to traditional steroid injections. A recent trial indicated that patients experienced sustained symptom relief up to six months post saline injection, while the effects of steroid injections diminished over time.

The Hydrodissection Procedure

The technique, known as hydrodissection, involves the use of ultrasound to guide a fine needle to the nerve’s location. Once positioned correctly, a sterile saline solution is injected to create space around the nerve, reducing friction and allowing for better movement. This process contrasts with steroid injections, which primarily function by alleviating inflammation.

According to Anupama Tandon, a radiologist at University College of Medical Sciences and Guru Teg Bahadur Hospital, “This relieves the pressure on the nerve and improves patients’ symptoms.”

Trial Design and Results

Conducted by Anindita Bose and a team at Mahatma Gandhi Medical College and Hospital, the trial involved 39 participants with persistent CTS symptoms lasting at least three months, despite prior treatments like medication or wrist splints. In total, 63 wrists were studied, as some participants had bilateral symptoms.

Each wrist was randomly assigned to one of three treatment groups: one received saline hydrodissection, another received a steroid injection without hydrodissection, and the third group received a saline solution containing steroid. Each treatment was thoroughly monitored using ultrasound technology, assessing pain levels, numbness, and nerve swelling over three months.

Results showed that while all treatments initially alleviated symptoms, only the saline hydrodissection group maintained significant improvements after three months, highlighting the long-term efficacy of this approach.

Clinical Implications and Future Directions

The findings from this trial are significant for individuals suffering from mild to moderate CTS, providing a non-invasive treatment option that requires no hospitalization and has minimal recovery complications. Treatment sessions lasted approximately 15 minutes, with mild side effects reported by some participants.

As radiologist Tandon noted, a patient who could not perform her typing job due to CTS experienced substantial symptom relief after hydrodissection, allowing her to return to work. This illustrates the procedure’s potential to improve quality of life.

While the results are promising, researchers acknowledge the need for larger studies to validate these findings and determine the longevity of the relief offered by saline injections. Ongoing research is planned to compare the effects of saline versus dextrose, a type of sugar, to further optimize treatment for carpal tunnel syndrome.